Tag: Yuka Daimon
Opportunities in Japan’s regenerative medicine, gene therapy markets
Japan emerges as a hub for regenerative medicine, with opportunities for foreign companies amid strict local regulations
Japan’s path for drug transfers
Japan’s pharma market demands careful regulatory and approval transfer compliance



















